Original Literature | Model OverView |
---|---|
Publication
Title
Dual role of oxidized LDL on the NF-kappaB signaling pathway.
Affiliation
INSERM U-466, CHU Rangueil, 31403 Toulouse, Cedex 4, France.
Abstract
Atherosclerosis is a slowly evolutive age-linked disease of large arteries,characterized by a local lipid deposition associated with a chronic inflammatoryresponse, leading potentially to acute plaque rupture, thrombosis and ischemicheart disease. Atherogenesis is a complex sequence of events associating firstexpression of adhesion molecules, recruitment of mononuclear cells to theendothelium, local activation of leukocytes and inflammation, lipid accumulationand foam cell formation. Low density lipoproteins (LDLs) become atherogenicafter undergoing oxidation by vascular cells, that transform them into highlybioreactive oxidized LDL (oxidized LDLs). Oxidized LDLs are involved in foamcell formation, and trigger proatherogenic events such as overexpression ofadhesion molecules, chemoattractant agents growth factors and cytokines involvedin the inflammatory process, cell proliferation and apoptosis. Moreover, thistoxic effect of oxidized LDLs plays probably a role in plaque erosion/ruptureand subsequent atherothrombosis. Several biological effects of oxidized LDLs aremediated through changes in the activity of transcription factors andsubsequently in gene expression. Oxidized LDLs exert a biphasic effect on theredox-sensitive transcription factor NF-kappaB, which can be activated therebyup-regulating proinflammatory gene expression, such as adhesion molecules,tissue factor, scavenger receptor LOX-1. On the other hand, higherconcentrations of oxidized LDLs may inhibit NF-kappaB activation triggered byinflammatory agents such as LPS, and may thereby exert an immunosuppressiveeffect. This review is an attempt to clarify the mechanism by which oxidizedLDLs may up- or down-regulate NF-kappaB, the role of NF-kappaB activation (orinhibition), and the consequences of the oxidized LDLs-mediated NF-kappaBdysregulation and their potential involvement in atherosclerosis.
PMID
15346645
|
Entity
Process
IkappaB-alpha
--
MO000000233
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m199
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000233 |
--
IKK-alpha:IKK-beta
--
MO000033291
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m11981
10
infinite
0
TRANSPATH | MO000033291 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
csml-variable:Double
m10
0
infinite
0
--
PDGJ2:PPARG
--
e100
cso30:c:Complex
cso30:i:CC_Cell_WithoutCellWall_
--
--
csml-variable:Double
m104
0
infinite
0
--
LOX1
--
e101
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m105
0
infinite
0
--
FasL
--
e102
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m106
0
infinite
0
--
c-myc
--
e103
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m107
0
infinite
0
--
TF
--
e104
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m108
0
infinite
0
--
csml-variable:Double
m109
0
infinite
0
--
AT1
--
e106
cso30:c:Protein
cso30:i:CC_Cell_WithoutCellWall_
--
csml-variable:Double
m110
0
infinite
0
--
IKK-alpha:IKK-beta:(IKK-gamma)2
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
MEKK3:IKK-alpha:IKK-beta:(IKK-gamma)2
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
MEKK3:IKK-alpha:IKK-beta{p}:(IKK-gamma)2
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
NIK:IKK-alpha:IKK-beta:(IKK-gamma)2
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
NIK:IKK-alpha:IKK-beta{p}:(IKK-gamma)2
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
PKC{active}:IKK-alpha:IKK-beta:(IKK-gamma)2
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
PKC{active}:IKK-alpha:IKK-beta{p}:(IKK-gamma)2
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
MEKK1:IKK-alpha:IKK-beta:(IKK-gamma)2
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
MEKK1:IKK-alpha:IKK-beta:(IKK-gamma)2
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
AKT:IKK-alpha:IKK-beta:(IKK-gamma)2
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
AKT:IKKA:IKKB{p}:(IKKG)2
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
MEKK2:IKK-alpha:IKK-beta:(IKK-gamma)2
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
Mekk2:IKK-alpha:IKK-beta{p}:(IKK-gamma)2
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
TBK1:IKKA:IKKb{p}:(IKKG)2
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
TBK1:IKKA:IKKB{p}:(IKKG)2
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
NF-kappaB:I-kappaB{alpha}
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
NF-kappaB:I-kappaB{alpha}{p}
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
NF-kappaB:I-kappaB{alpha}{p}{ub}
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
protein remnants
--
e35
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
NF-kappaB{active}
--
e36
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
NF-kappaB
--
e37
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m37
0
infinite
0
--
csml-variable:Double
m38
0
infinite
0
--
TNF-alpha:NF-kappaB
--
e39
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
csml-variable:Double
m40
0
infinite
0
--
IL-1:NF-kappaB
--
e41
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m41
0
infinite
0
--
IL-1
--
e42
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m42
0
infinite
0
--
csml-variable:Double
m43
0
infinite
0
--
ICAM1:NFkapapB
--
e44
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m46
0
infinite
0
--
ICAM1
--
e45
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m47
0
infinite
0
--
csml-variable:Double
m48
0
infinite
0
--
Eselectin:NFkappaB
--
e47
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m49
0
infinite
0
--
csml-variable:Double
m63
0
infinite
0
--
csml-variable:Double
m64
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
BCL-xL
--
e63
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m65
0
infinite
0
--
csml-variable:Double
m66
0
infinite
0
--
csml-variable:Double
m67
0
infinite
0
--
csml-variable:Double
m68
0
infinite
0
--
csml-variable:Double
m69
0
infinite
0
--
NF-kappaB:I-kappaB{alpha}
--
e69
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m71
0
infinite
0
--
csml-variable:Double
m7
0
infinite
0
--
UV
--
e70
cso30:c:EntityBiologicalEnvironment
cso30:i:CC_Cell_WithoutCellWall_
--
--
csml-variable:Double
m72
0
infinite
0
--
NF-kappaB
--
e71
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m73
0
infinite
0
--
PI3K:NFkappaB:IkappaBalpha
--
e72
cso30:c:Complex
cso30:i:CC_Cell_WithoutCellWall_
--
csml-variable:Double
m75
0
infinite
0
--
PI3K:IKappaBalpha
--
e73
cso30:c:SmallMolecule
cso30:i:CC_Cell_WithoutCellWall_
--
--
csml-variable:Double
m76
0
infinite
0
--
H2O2
--
e74
cso30:c:SmallMolecule
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m77
0
infinite
0
--
csml-variable:Double
m78
0
infinite
0
--
NAC
--
e76
cso30:c:SmallMolecule
cso30:i:CC_Cell_WithoutCellWall_
--
csml-variable:Double
m79
0
infinite
0
--
calphostin C
--
e77
cso30:c:SmallMolecule
cso30:i:CC_Cell_WithoutCellWall_
--
csml-variable:Double
m80
0
infinite
0
--
Lyso-PC
--
e78
cso30:c:SmallMolecule
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m81
0
infinite
0
--
Tyrosine kinase
--
e79
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m82
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
Tyrosine kinase {active}
--
e80
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m83
0
infinite
0
--
csml-variable:Double
m85
0
infinite
0
--
oxidised LDL
--
e83
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m86
0
infinite
0
--
sphingosine-1-phosphate
--
e84
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m87
0
infinite
0
--
LOX1
--
e85
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m88
0
infinite
0
--
oxidized LDL:LOX1
--
e86
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m89
0
infinite
0
--
ROS
--
e87
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m90
0
infinite
0
--
LPS:TLRs
--
e88
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m91
0
infinite
0
--
csml-variable:Double
m93
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
phtohaemagglutinin
--
e90
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m94
0
infinite
0
--
IL-2R
--
e91
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m95
0
infinite
0
--
PPAR-gamma
--
e92
cso30:c:Protein
cso30:i:CC_Cell_WithoutCellWall_
--
csml-variable:Double
m96
0
infinite
0
--
9-HODE
--
e93
cso30:c:SmallMolecule
cso30:i:CC_Cell_WithoutCellWall_
--
--
csml-variable:Double
m97
0
infinite
0
--
9-HODE:PPARG
--
e94
cso30:c:Complex
cso30:i:CC_Cell_WithoutCellWall_
--
--
csml-variable:Double
m98
0
infinite
0
--
13-HODE
--
e95
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m99
0
infinite
0
--
13-HODE:PPARG
--
e96
cso30:c:Complex
cso30:i:CC_Cell_WithoutCellWall_
--
--
csml-variable:Double
m100
0
infinite
0
--
HETE
--
e97
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m101
0
infinite
0
--
HETE:PPARG
--
e98
cso30:c:Complex
cso30:i:CC_Cell_WithoutCellWall_
--
--
csml-variable:Double
m102
0
infinite
0
--
PDGJ2
--
e99
cso30:c:SmallMolecule
cso30:i:CC_Cell_WithoutCellWall_
--
--
csml-variable:Double
m103
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c149 : 1
stoichiometry:c2 : 1
m92*m81*0.1
nodelay
--
0
PMID: 15346645, 9555862, 1381720, 8622597, 9084506 Lysophosphatidylcholine (Lyso-PC) elicited PKC and tyrosine kinases activation and subsequent NF-kB activation and overexpression of ICAM-1, VCAM-1 and MCP-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c21 : 1
stoichiometry:c24 : 1
m13*m17*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m18*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m6*m17*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
m20*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m5*m17*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m22*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m12*m17*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m24*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m17*m15*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m26*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c250 : 1
stoichiometry:c4 : 1
m174*m86*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m14*m17*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m28*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m11*m17*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m30*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c57 : 1
stoichiometry:c56 : 1
m32*m29*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex, which in turn phosphorylates IkB. PMID: 15346645 Upon activation, IkB is rapidly phosphorylated on two serine residues (ser-32 and ser-36 in IkBa, ser-19 and ser-23 in IkBb).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c60 : 1
stoichiometry:c59 : 1
m32*m31*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c63 : 1
stoichiometry:c62 : 1
m32*m27*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex, which in turn phosphorylates IkB. PMID: 15346645 Upon activation, IkB is rapidly phosphorylated on two serine residues (ser-32 and ser-36 in IkBa, ser-19 and ser-23 in IkBb).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c66 : 1
stoichiometry:c65 : 1
m32*m21*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex, which in turn phosphorylates IkB. PMID: 15346645 Upon activation, IkB is rapidly phosphorylated on two serine residues (ser-32 and ser-36 in IkBa, ser-19 and ser-23 in IkBb).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c69 : 1
stoichiometry:c68 : 1
m32*m19*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex, which in turn phosphorylates IkB. PMID: 15346645 Upon activation, IkB is rapidly phosphorylated on two serine residues (ser-32 and ser-36 in IkBa, ser-19 and ser-23 in IkBb).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c72 : 1
stoichiometry:c71 : 1
m32*m23*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex, which in turn phosphorylates IkB. PMID: 15346645 Upon activation, IkB is rapidly phosphorylated on two serine residues (ser-32 and ser-36 in IkBa, ser-19 and ser-23 in IkBb).
p3
p3
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c249 : 1
stoichiometry:c6 : 1
m3902*m86*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c75 : 1
stoichiometry:c74 : 1
m32*m25*0.1
nodelay
--
0
PMID: 15346645 Activated IKK-kinases induce both phosphorylation of the catalytic subunits and activation of the IKK complex, which in turn phosphorylates IkB. PMID: 15346645 Upon activation, IkB is rapidly phosphorylated on two serine residues (ser-32 and ser-36 in IkBa, ser-19 and ser-23 in IkBb).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m33*0.1
nodelay
--
0
PMID: 15346645 This leads to IkB ubiquitination and subsequent degradation by the 26S proteasome.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c168 : 1
stoichiometry:c82 : 1
m36*m86*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL)immunoreceptors. PMID: 15346645, 12586748 oxLDL-mediated NF-kB nuclear translocation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m37*m38*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
m39*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m40*m37*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c91 : 1
m41*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
m43*m37*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m46*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
p4
p4
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c247 : 1
stoichiometry:c8 : 1
m1115*m86*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
p40
p40
cso30:i:ME_DNABinding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c145 : 1
stoichiometry:c146 : 1
stoichiometry:c100 : 1
m37*m7*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors. PMID: 15346645, 11557664 This effect is mediated by oxidative stress and PKC as assessed bythe inhibition of NF-kB DNA binding and transcriptionof VCAM-1 gene by the antioxidant NAC and calphostin C.
p41
p41
cso30:i:ME_Transcription
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c144 : 1
stoichiometry:c147 : 1
stoichiometry:c148 : 1
stoichiometry:c102 : 1
m10*m78*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m48*m37*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
m49*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c110 : 1
stoichiometry:c109 : 1
m63*m37*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c112 : 1
m64*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
stoichiometry:c113 : 1
m66*m37*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m67*0.1
nodelay
--
0
PMID: 15346645, 11499717, 11795276 The released NF-kB dimer then translocates to the nucleus where it binds to specific promoters and activates the transcriptionof a wide variety of target genes including genes of cytokines (IL-1, TNF-a) adhesion molecules (VCAM-1, ICAM-1, E-selectin), regulators of apoptosis (c-IAPs, Bcl-xL) immunoreceptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
m37*0.1
nodelay
--
0
PMID: 15346645 A second mechanism of autoregulation of the NF-kB/IkB system is also induced by NF-kB itself which elicits the synthesis of its own inhibitor IkB. The newly synthetized IkBa proteins enter the nucleus to bind activated NF-kB and carry it to the cytoplasm,thereby terminating the activation of gene expression.
p49
p49
cso30:i:ME_Translation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c121 : 1
m69*0.1
nodelay
--
0
PMID: 15346645 A second mechanism of autoregulation of the NF-kB/IkB system is also induced by NF-kB itself which elicits the synthesis of its own inhibitor IkB. The newly synthetized IkBa proteins enter the nucleus to bind activated NF-kB and carry it to the cytoplasm,thereby terminating the activation of gene expression.
p5
p5
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c248 : 1
stoichiometry:c10 : 1
m1116*m86*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
p50
p50
cso30:i:ME_Translocation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c123 : 1
m199*0.1
nodelay
--
0
PMID: 15346645 A second mechanism of autoregulation of the NF-kB/IkB system is also induced by NF-kB itself which elicits the synthesis of its own inhibitor IkB. The newly synthetized IkBa proteins enter the nucleus to bind activated NF-kB and carry it to the cytoplasm,thereby terminating the activation of gene expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m37*m70*0.1
nodelay
--
0
PMID: 15346645 A second mechanism of autoregulation of the NF-kB/IkB system is also induced by NF-kB itself which elicits the synthesis of its own inhibitor IkB. The newly synthetized IkBa proteins enter the nucleus to bind activated NF-kB and carry it to the cytoplasm,thereby terminating the activation of gene expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c128 : 1
m71*0.1
nodelay
--
0
PMID: 15346645 A second mechanism of autoregulation of the NF-kB/IkB system is also induced by NF-kB itself which elicits the synthesis of its own inhibitor IkB. The newly synthetized IkBa proteins enter the nucleus to bind activated NF-kB and carry it to the cytoplasm,thereby terminating the activation of gene expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c131 : 1
stoichiometry:c130 : 1
m73*m72*0.1
nodelay
--
0
PMID: 15346645 UV radiation-induced NF-kB activation does not involve IkBa phosphorylation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c133 : 1
stoichiometry:c134 : 1
m33*m74*0.1
nodelay
--
0
PMID: 15346645, 10488062, 10373503, 10723801 phosphorylation of IkBa at tyrosine 42, that may bind the SH2 domain ofPI3-kinase which pulls it away from NF-kB.
p55
p55
cso30:i:ME_Dissociation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c135 : 1
stoichiometry:c136 : 1
stoichiometry:c137 : 1
m75*0.1
nodelay
--
0
PMID: 15346645, 10488062, 10373503, 10723801 phosphorylation of IkBa at tyrosine 42, that may bind the SH2 domain ofPI3-kinase which pulls it away from NF-kB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c140 : 1
stoichiometry:c139 : 1
m73*m77*0.1
nodelay
--
0
PMID: 15346645 NF-kB is a redox-sensitive transcription factorwhich is activated by intracellular reactive oxygen species (ROS), such as H2O2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c143 : 1
stoichiometry:c142 : 1
m73*m78*0.1
nodelay
--
0
PMID: 15346645, 11557664 13-HPODE (13-hydroperoxyoctadecadienoic acid) induces NF-kB activation and subsequent overexpression of the vascular cell adhesion molecule-1 (VCAM-1) in porcine vascular SMCs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c152 : 1
stoichiometry:c151 : 1
m73*m81*0.1
nodelay
--
0
PMID: 15346645, 9555862, 1381720, 8622597, 9084506 Lysophosphatidylcholine (Lyso-PC) elicited PKC and tyrosine kinases activation and subsequent NF-kB activation and overexpression of ICAM-1, VCAM-1 and MCP-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c153 : 1
m81*0.1
nodelay
--
0
PMID: 15346645, 9555862, 1381720, 8622597, 9084506 Lysophosphatidylcholine (Lyso-PC) elicited PKC and tyrosine kinases activation and subsequent NF-kB activation and overexpression of ICAM-1, VCAM-1 and MCP-1.
p6
p6
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c251 : 1
stoichiometry:c12 : 1
m44*m86*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c155 : 1
m81*0.1
nodelay
--
0
PMID: 15346645, 9555862, 1381720, 8622597, 9084506 Lysophosphatidylcholine (Lyso-PC) elicited PKC and tyrosine kinases activation and subsequent NF-kB activation and overexpression of ICAM-1, VCAM-1 and MCP-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c157 : 1
m81*0.1
nodelay
--
0
PMID: 15346645, 9555862, 1381720, 8622597, 9084506 Lysophosphatidylcholine (Lyso-PC) elicited PKC and tyrosine kinases activation and subsequent NF-kB activation and overexpression of ICAM-1, VCAM-1 and MCP-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c161 : 1
stoichiometry:c160 : 1
m82*m81*0.1
nodelay
--
0
PMID: 15346645, 9555862, 1381720, 8622597, 9084506 Lysophosphatidylcholine (Lyso-PC) elicited PKC and tyrosine kinases activation and subsequent NF-kB activation and overexpression of ICAM-1, VCAM-1 and MCP-1.
p63
p63
cso30:i:ME_UnknownActivation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c164 : 1
stoichiometry:c163 : 1
m1812*m85*0.1
nodelay
--
0
PMID: 15346645 Low HNE concentration induces MAPK activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c165 : 1
stoichiometry:c167 : 1
stoichiometry:c166 : 1
m73*m90*0.1
nodelay
--
0
PMID: 15346645, 8876974 Moderate concentrations of oxidized LDLs trigger a rapid and dose-dependent activation of NF-kB. PMID: 15346645 ROS are generated by a DPI-sensitive oxidase system activated through signaling triggered by binding ofoxidized LDLs to LOX-1 (lectin-like ox-LDL receptor-1) in endothelial cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c170 : 1
m86*0.1
nodelay
--
0
PMID: 15346645, 8657285 Another survival mechanism that regulates cell death and proliferation induced by oxidized LDLs is the generation of bioactive sphingolipid metabolites, for instance sphingosine-1-phosphate (S1-P).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c171 : 1
stoichiometry:c173 : 1
stoichiometry:c172 : 1
m73*m87*0.1
nodelay
--
0
PMID: 15346645, 10567432, 9826677 S1-P is involved in NF-kB activation mediated by inflammatory cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c174 : 1
stoichiometry:c175 : 1
stoichiometry:c176 : 1
m86*m88*0.1
nodelay
--
0
PMID: 15346645 ROS are generated by a DPI-sensitive oxidase system activated through signaling triggered by binding ofoxidized LDLs to LOX-1 (lectin-like ox-LDL receptor-1) in endothelial cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c177 : 1
stoichiometry:c178 : 1
m89*0.1
nodelay
--
0
PMID: 15346645 ROS are generated by a DPI-sensitive oxidase system activated through signaling triggered by binding ofoxidized LDLs to LOX-1 (lectin-like ox-LDL receptor-1) in endothelial cells.
p69
p69
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c179 : 1
stoichiometry:c180 : 1
stoichiometry:c181 : 1
m157177*m3962*0.1
nodelay
--
0
PMID: 15346645, 9351352, 7583531, 8690807, 11502209, 13679995 oxidized LDLs inhibit the LPS-induced NF-kB activation and subsequent expression of TNF-a,IL-1b and PAF-receptor in macrophages.
p7
p7
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c252 : 1
stoichiometry:c14 : 1
m45*m86*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
p70
p70
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c182 : 1
stoichiometry:c184 : 1
stoichiometry:c188 : 1
stoichiometry:c240 : 1
stoichiometry:c183 : 1
m73*m91*0.1
nodelay
--
0
PMID: 15346645, 9351352, 7583531, 8690807, 11502209, 13679995 oxidized LDLs inhibit the LPS-induced NF-kB activation and subsequent expression of TNF-a,IL-1b and PAF-receptor in macrophages. PMID: 15346645, 9888865 oxidized LDLs significantly enhanced TF expression induced by LPS in human monocytes, whereas other reports have shown that lysoPC induce a decrease in both NFkB activation and TF expression induced by LPS.
p71
p71
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c185 : 1
stoichiometry:c187 : 1
stoichiometry:c189 : 1
stoichiometry:c186 : 1
m37*m91*0.1
nodelay
--
0
PMID: 15346645, 9351352, 7583531, 8690807, 11502209, 13679995 oxidized LDLs inhibit the LPS-induced NF-kB activation and subsequent expression of TNF-a,IL-1b and PAF-receptor in macrophages.
p72
p72
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c191 : 1
stoichiometry:c192 : 1
stoichiometry:c193 : 1
stoichiometry:c190 : 1
m37*m91*0.1
nodelay
--
0
PMID: 15346645, 9351352, 7583531, 8690807, 11502209, 13679995 oxidized LDLs inhibit the LPS-induced NF-kB activation and subsequent expression of TNF-a,IL-1b and PAF-receptor in macrophages.
p73
p73
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c195 : 1
stoichiometry:c196 : 1
stoichiometry:c197 : 1
stoichiometry:c194 : 1
m37*m91*0.1
nodelay
--
0
PMID: 15346645, 9351352, 7583531, 8690807, 11502209, 13679995 oxidized LDLs inhibit the LPS-induced NF-kB activation and subsequent expression of TNF-a,IL-1b and PAF-receptor in macrophages.
p74
p74
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c198 : 1
stoichiometry:c200 : 1
stoichiometry:c201 : 1
stoichiometry:c199 : 1
m73*m94*0.1
nodelay
--
0
PMID: 15346645, 9882624 phytohaemagglutinin (PHA)-induced NF-kB activation and subsequent IL-2 receptor expression in human T-lymphocytes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c203 : 1
stoichiometry:c204 : 1
stoichiometry:c205 : 1
stoichiometry:c202 : 1
m37*m94*0.1
nodelay
--
0
PMID: 15346645, 9882624 phytohaemagglutinin (PHA)-induced NF-kB activation and subsequent IL-2 receptor expression in human T-lymphocytes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c206 : 1
stoichiometry:c208 : 1
stoichiometry:c209 : 1
stoichiometry:c207 : 1
m32*m91*0.1
nodelay
--
0
PMID: 15346645, 10206970 HNE prevents the LPS-induced IkBa phosphorylation in THP-1 monocytic cells.
p77
p77
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c212 : 1
stoichiometry:c213 : 1
stoichiometry:c211 : 1
m34*m91*0.1
nodelay
--
0
PMID: 15346645, 10698969, 10446139 HNE (like oxidized LDLS) is also able to inhibit the proteasome activity and subsequent proteolysis of IkBa, possibly through a modification of proteasome proteins by 4-HNE.
p78
p78
cso30:i:ME_Binding
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c214 : 1
stoichiometry:c215 : 1
stoichiometry:c216 : 1
m96*m97*0.1
nodelay
--
0
PMID: 15346645, 9568715, 9422508, 12223313 Oxidized PUFAs, such as 9-HODE and 13-HODE, prostaglandin J2 and HETE, have been identified as endogenous ligands and activators of PPARg.
p79
p79
cso30:i:ME_Binding
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c217 : 1
stoichiometry:c218 : 1
stoichiometry:c219 : 1
m96*m99*0.1
nodelay
--
0
PMID: 15346645, 9568715, 9422508, 12223313 Oxidized PUFAs, such as 9-HODE and 13-HODE, prostaglandin J2 and HETE, have been identified as endogenous ligands and activators of PPARg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m11981*m16*0.1
nodelay
--
0
PMID: 15346645 IKK is an heterodimer IKKa/IKKb associated with either dimer or trimer of IKKg.
p80
p80
cso30:i:ME_Binding
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c220 : 1
stoichiometry:c221 : 1
stoichiometry:c222 : 1
m96*m101*0.1
nodelay
--
0
PMID: 15346645, 9568715, 9422508, 12223313 Oxidized PUFAs, such as 9-HODE and 13-HODE, prostaglandin J2 and HETE, have been identified as endogenous ligands and activators of PPARg.
p81
p81
cso30:i:ME_Binding
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c223 : 1
stoichiometry:c224 : 1
stoichiometry:c225 : 1
m96*m103*0.1
nodelay
--
0
PMID: 15346645, 9568715, 9422508, 12223313 Oxidized PUFAs, such as 9-HODE and 13-HODE, prostaglandin J2 and HETE, have been identified as endogenous ligands and activators of PPARg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c226 : 1
stoichiometry:c227 : 1
m37*0.1
nodelay
--
0
PMID: 15346645, 10764682, 10085242 NF-kB may enhance the pro-apoptotic effect of oxidized LDLs by up-regulating LOX-1 expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c228 : 1
stoichiometry:c229 : 1
m37*0.1
nodelay
--
0
PMID: 15346645, 10508269, 10022897, 10234031 NF-kB may also up-regulate the expression of pro-apoptotic genes such as Fas ligand, Fas (Cd95), c-myc and p53,thereby sensitizing cells to apoptotic stimuli
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c230 : 1
stoichiometry:c231 : 1
m37*0.1
nodelay
--
0
PMID: 15346645, 10508269, 10022897, 10234031 NF-kB may also up-regulate the expression of pro-apoptotic genes such as Fas ligand, Fas (Cd95), c-myc and p53,thereby sensitizing cells to apoptotic stimuli
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c232 : 1
stoichiometry:c233 : 1
m37*0.1
nodelay
--
0
PMID: 15346645, 10508269, 10022897, 10234031 NF-kB may also up-regulate the expression of pro-apoptotic genes such as Fas ligand, Fas (Cd95), c-myc and p53,thereby sensitizing cells to apoptotic stimuli
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c234 : 1
stoichiometry:c235 : 1
m37*0.1
nodelay
--
0
PMID: 15346645, 10508269, 10022897, 10234031 NF-kB may also up-regulate the expression of pro-apoptotic genes such as Fas ligand, Fas (Cd95), c-myc and p53,thereby sensitizing cells to apoptotic stimuli
p87
p87
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c236 : 1
stoichiometry:c238 : 1
stoichiometry:c239 : 1
stoichiometry:c237 : 1
m91*m86*0.1
nodelay
--
0
PMID: 15346645, 9888865 oxidized LDLs significantly enhanced TF expression induced by LPS in human monocytes, whereas other reports have shown that lysoPC induce a decrease in both NFkB activation and TF expression induced by LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c242 : 1
stoichiometry:c241 : 1
m37*0.1
nodelay
--
0
PMID: 15346645, 11034947 NF-kB-mediated overexpression of Angiotensin Receptor-1 (AT1) which may up-regulate LOX-1 expression and enhances the toxicity of oxidized LDLs.
p89
p89
cso30:i:ME_Translation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c244 : 1
stoichiometry:c243 : 1
m109*0.1
nodelay
--
0
PMID: 15346645, 11034947 NF-kB-mediated overexpression of Angiotensin Receptor-1 (AT1) which may up-regulate LOX-1 expression and enhances the toxicity of oxidized LDLs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
m1593*0.1
nodelay
--
0
PMID: 15346645 IKK is an heterodimer IKKa/IKKb associated with either dimer or trimer of IKKg.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c246 : 1
stoichiometry:c245 : 1
m110*0.1
nodelay
--
0
PMID: 15346645, 11034947 NF-kB-mediated overexpression of Angiotensin Receptor-1 (AT1) which may up-regulate LOX-1 expression and enhances the toxicity of oxidized LDLs.
p91
p91
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c253 : 1
stoichiometry:c255 : 1
stoichiometry:c254 : 1
m92*m86*0.1
nodelay
--
0
PMID: 15346645 In response to upstream stimuli, IKK-kinases are activated and recruited to the complex via IKKg.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--